Background and Aims: Non-cystic fibrosis bronchiectasis has a diverse cause unique to the population under study. The prevalence of bronchiectasis is increasing especially in Asian population; however, the aetiology and profile of bronchiectasis in Malaysia as a high tuberculosis endemic area are unknown.
Results: 115 patients with a mean age (AESD) of 64.2 AE 14.4 were enrolled. 67 (58.3%) were females with the population comprising of 57 Malays (49.6%) followed by 48 Chinese (41.7%) and 10 Indians (8.7%).5.2% were smokers. The common aetiologies were post infective 41(35.7%), post tuberculosis 36(31.3%), idiopathic 32(27.8%) and immunodeficiency 4(3.5%).Mean FEV1 was 1.27(AE0.47), mean FVC was 1.61 (AE 0.53), mean predicted percentage FEV1 55.4(AE 22.0), mean predicted percentage FVC 53.02 (AE 18.48) . Mean FEV1/FVC ratio was 81.1% AE 22.1. Microbiologic profiling revealed Candida sp. in 30(26%) of patients, Mycobacterium tuberculosis in 23(20%), no growth in 20(17%), Pseudomonas sp. in 8 (7%).The lowest mean (SD) FEV1 was observed in subjects with Pseudomonas aeruginosa (P = 0.004).Bronchiectasis distribution was most common in the right lower lobe in all aetiologies (P = 0.031) and significantly more common in post tuberculosis bronchiectasis (P = 0.008).Long term antimicrobial therapy reduces exacerbation rate per year (P = 0.003). 96.5% of patients reported exacerbations over the past 12 months with the mean rate of 4.08 AE 3.38 per year. Background and Aims: In pulmonary tuberculosis (TB) patients, acute respiratory distress syndrome is a common cause in the intensive care unit (ICU) and is associated with high mortality and morbidity. Although high mortality in pulmonary tuberculosis patients requiring ICU care are well known, factors influencing ICU care from admitted general ward initially is not well known.
Methods: A nested case-control study was performed among TB patients recruited from July 2013 to march 2017 in National Medical Center in Korea. Cases included 32 patients with pulmonary TB admitted ICU from general ward and 55 controls were selected from 623 TB patients requiring hospital admission after matching with age, sex, and radiologic findings of extent of tuberculosis.
Results: Among 1:2 matched cases and controls, the range of age, sex and the extent of TB on radiologic findings were distributed even. Patients who were referred to ICU have lasted their symptoms longer before admission to hospital. The level of serum albumin (g/dL) and haemoglobin (g/dL) were lower in patients who had needed intensive care (P < 0.001 and P = 0.005, respectively). The higher level of C-reactive protein (CRP) was found in patients who were referred to ICU (P = 0.005). The most common cause for ICU referral was respiratory failure (87.5%). After adjusting the duration of symptom persistence before admission, BMI, and the level of haemoglobin and CRP, which were also satisfied to be put into the multivariate analysis, the level of albumin was found to significantly predict for the risk of intensive care within the admission period (Q1 albumin<2.0; OR 17.78, 95% CI 13.32-240.32, and 2.0-3.0; OR 7.05, 95% CI 0.70-71.08, p for trend 0.04, respectively).
Conclusion:
This study showed the level of albumin at admission was crucial to predict the admission of ICU care in patients with pulmonary TB. 
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Background and Aims: Multidrug-resistant tuberculosis worsening global health problem. Indonesia is one of 10 MDR TB highest burden countries worldwide, with estimated 6.800 cases every year. Cure rate of MDR TB treatment were very low about 52%, and in our setting only 51% compare with high cost and length of treatment since then WHO recommended shorter regimen (STR) for MDR TB treatment that reduce duration of treatment from 20 to 9 until 11 months. Some studies showed that STR increase cure rate about 80%. In our Hospital we started treat patient using STR in September 2017 there for we still evaluate the outcome of this regimen, but in this report we try to evaluate characteristic of patient treated with STR compare with standard and individual regimen. 
